ANAPTYSBIO, INC financial data

Symbol
ANAB on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 869% % -16%
Return On Equity -1101% % -282%
Return On Assets -21% % 43%
Operating Margin -17% % 93%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27,688,470 shares -9%
Common Stock, Shares, Outstanding 27,575,152 shares -9.4%
Entity Public Float $487,837,306 USD 33%
Common Stock, Value, Issued $28,000 USD -6.7%
Weighted Average Number of Shares Outstanding, Basic 27,833,000 shares -3.7%
Weighted Average Number of Shares Outstanding, Diluted 29,018,000 shares 0.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $169,467,000 USD 196%
Research and Development Expense $31,407,000 USD -26%
General and Administrative Expense $45,142,000 USD 6.3%
Operating Income (Loss) $28,675,000 USD 81%
Nonoperating Income (Expense) $55,878,000 USD -206%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $84,553,000 USD
Income Tax Expense (Benefit) $77,000 USD
Net Income (Loss) Attributable to Parent $84,630,000 USD 49%
Earnings Per Share, Basic -2 USD/shares 55%
Earnings Per Share, Diluted -2 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $109,833,000 USD -43%
Assets, Current $330,650,000 USD -26%
Property, Plant and Equipment, Net $1,500,000 USD -13%
Operating Lease, Right-of-Use Asset $12,994,000 USD -12%
Other Assets, Noncurrent $256,000 USD 0%
Assets $353,098,000 USD -28%
Accounts Payable, Current $2,893,000 USD -19%
Employee-related Liabilities, Current $9,007,000 USD 14%
Accrued Liabilities, Current $33,171,000 USD -14%
Liabilities, Current $38,104,000 USD -13%
Operating Lease, Liability, Noncurrent $12,566,000 USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $47,000 USD -94%
Retained Earnings (Accumulated Deficit) $822,173,000 USD -11%
Stockholders' Equity Attributable to Parent $29,416,000 USD -135%
Liabilities and Equity $353,098,000 USD -28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,700,000 USD 71%
Net Cash Provided by (Used in) Financing Activities $28,590,000 USD -110%
Net Cash Provided by (Used in) Investing Activities $14,847,000 USD -78%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 27,575,152 shares -9.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $24,443,000 USD -238%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $109,833,000 USD -43%
Interest Paid, Excluding Capitalized Interest, Operating Activities $18,100,000 USD
Deferred Tax Assets, Valuation Allowance $187,185,000 USD 24%
Deferred Tax Assets, Gross $193,532,000 USD 23%
Operating Lease, Liability $14,606,000 USD -11%
Payments to Acquire Property, Plant, and Equipment $35,000 USD 30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $85,342,000 USD 47%
Lessee, Operating Lease, Liability, to be Paid $16,485,000 USD -13%
Property, Plant and Equipment, Gross $8,509,000 USD 3.8%
Operating Lease, Liability, Current $2,040,000 USD 8.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,685,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,607,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,879,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,766,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $70,724,000 USD -2.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $6,911,000 USD 38%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,849,000 USD 3%
Operating Lease, Payments $620,000 USD 3%
Additional Paid in Capital $792,682,000 USD -3.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $146,000 USD -10%
Share-based Payment Arrangement, Expense $35,750,000 USD 5.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%